Cargando…

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

The prognostic value of flow cytometric parameters and tumour growth rate of melanoma metastases under the mouse renal capsule was investigated for tumours from 117 consecutive patients referred to the Helsinki University Central Hospital Melanoma Team. DNA flow cytometry (FCM) was interpretable for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhonen, T., Pyrhönen, S., Laasonen, A., Wasenius, V. M., Asko-Seljavaara, S., Franssila, K., Kangas, L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977937/ https://www.ncbi.nlm.nih.gov/pubmed/1520590

Ejemplares similares

DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.
por: Muhonen, T., et al.
Publicado: (1991)

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.
por: Kouri, M., et al.
Publicado: (1990)

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
por: Hietanen, P., et al.
Publicado: (1995)

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
por: Niskanen, E., et al.
Publicado: (1997)

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.
por: Hemmer, S., et al.
Publicado: (1998)

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.
por: Sjöström, J., et al.
Publicado: (1998)

DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours).
por: van der Mey, A. G., et al.
Publicado: (1991)

Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
por: Forster, G., et al.
Publicado: (1992)

Prognostic Impact of DNA-Image-Cytometry in Neuroendocrine (Carcinoid) Tumours
por: Raatz, H., et al.
Publicado: (2004)

Prognostic Impact of DNA-Image-Cytometry in Neuroendocrine (Carcinoid) Tumours
por: Hauptmann, Steffen
Publicado: (2006)

Prognostic Impact of DNA-Image-Cytometry in Neuroendocrine (Carcinoid) Tumours
por: Petersen, I.
Publicado: (2006)

Cell-cycle distribution of urothelial tumour cells as measured by flow cytometry.
por: Collste, L. G., et al.
Publicado: (1979)

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
por: Riccardi, A., et al.
Publicado: (1989)

DNA analysis of breast tumour fine needle aspirates using flow cytometry.
por: Levack, P. A., et al.
Publicado: (1987)

Recent Advances on Multi-Parameter Flow Cytometry to Characterize Antimicrobial Treatments
por: Léonard, Lucie, et al.
Publicado: (2016)

An Introduction to Flow Cytometry
por: Camplejohn, R.S.
Publicado: (1992)

Practical Flow Cytometry
por: Blair, Owen C.
Publicado: (1985)

Flow Cytometry and Sorting
por: Dive, C.
Publicado: (1991)

Flow Cytometry Bioinformatics
por: O'Neill, Kieran, et al.
Publicado: (2013)

DNA Aneuploidy by Flow Cytometry Is an Independent Prognostic Factor in Gastric Cancer
por: Abad, Mar, et al.
Publicado: (1998)

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
por: Wilson, G. D., et al.
Publicado: (1988)

Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry.
por: Perez, D. J., et al.
Publicado: (1981)

Limits of Flow-Cytometry Histogram Analysis Methods to Assess Bladder Tumour Antigen Expression
por: Chabanas, Agnès, et al.
Publicado: (1997)

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours
por: Hartana, Ciputra Adijaya, et al.
Publicado: (2016)

Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours
por: Ricklefs, Franz L., et al.
Publicado: (2019)

Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry
por: Edgar, Robert H., et al.
Publicado: (2020)

MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?
por: Pessach, Ilias, et al.
Publicado: (2022)

Guide to Flow Cytometry Methods
por: Camplejohn, R.S.
Publicado: (1992)

Flow cytometry data standards
por: Spidlen, Josef, et al.
Publicado: (2011)

Guidelines for the use of flow cytometry
por: Veldhoen, Marc
Publicado: (2017)

Clinical Flow Cytometry in 2019
por: Psarra, Katherina
Publicado: (2019)

Advances in Intraoperative Flow Cytometry
por: D’Amato Figueiredo, Marcos V., et al.
Publicado: (2022)

Flow Cytometry: The Next Revolution
por: Robinson, J. Paul, et al.
Publicado: (2023)

Oncocytic tumours of the salivary gland, kidney, and thyroid: nuclear DNA patterns studied by flow cytometry.
por: Rainwater, L. M., et al.
Publicado: (1986)

Functional detection of MDRI/P190 mediated multidrug resistance in tumour cells by flow cytometry
Publicado: (1996)

Flow: Statistics, visualization and informatics for flow cytometry
por: Frelinger, Jacob, et al.
Publicado: (2008)

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.
por: Blomqvist, C., et al.
Publicado: (1996)

Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.
por: Armengol, G., et al.
Publicado: (1997)

Prognostic factors in prostate cancer
por: Buhmeida, A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6ej6lshno6cbua38etj6togauf